GlycoMimetics, Inc.
GLYC
$0.2747
$0.01315.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 10.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 10.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 10.00K |
| SG&A Expenses | 5.08M | 4.01M | 4.07M | 5.09M | 4.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.32M | 5.72M | 10.36M | 11.12M | 9.60M |
| Operating Income | -5.32M | -5.72M | -10.36M | -11.12M | -9.59M |
| Income Before Tax | -7.22M | -9.82M | -10.10M | -10.74M | -9.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.22M | -9.82M | -10.10M | -10.74M | -9.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.22M | -9.82M | -10.10M | -10.74M | -9.08M |
| EBIT | -5.32M | -5.72M | -10.36M | -11.12M | -9.59M |
| EBITDA | -5.32M | -5.71M | -10.35M | -11.10M | -9.57M |
| EPS Basic | -0.11 | -0.15 | -0.16 | -0.17 | -0.14 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.10 | -0.10 | -0.09 |
| EPS Diluted | -0.11 | -0.15 | -0.16 | -0.17 | -0.14 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.10 | -0.10 | -0.09 |
| Average Basic Shares Outstanding | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M |
| Average Diluted Shares Outstanding | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |